Kunkel Jay K. 4

What Happened

• Jay K. Kunkel, a director of Varex Imaging Corp (VREX), received an award of 12,331 deferred stock units (DSUs) reported as a grant on 2026-02-12. The grant price is $0.00 (no cash purchase); the DSUs are a derivative compensation award rather than an open-market buy.
• Each DSU converts into one share of Varex common stock (1:1). The DSUs vest 100% on the earlier of (i) one year from the grant date or (ii) the next annual meeting; vested shares will be delivered upon the earlier of the third anniversary of the grant, a change in control, or the reporting person’s termination of service.

Key Details

• Transaction date: 2026-02-12; Form filed 2026-02-13 (timely filing).
• Transaction type/code: Award/Grant (A); derivative instrument (Deferred Stock Units).
• Amount: 12,331 DSUs; grant price reported $0.00.
• Conversion: F1 — each DSU converts one-for-one into common stock.
• Vesting/delivery: F2 — 100% vests by the earlier of one year post-grant or the next annual meeting; delivery upon earliest of 3rd anniversary, change in control, or termination.
• Shares owned after transaction: Not specified in the provided filing.
• Notes: This is a compensation award (routine for directors) and not an open-market purchase or sale; it should be interpreted as a grant of deferred equity rather than an immediate bullish purchase.

Context

• Deferred stock units are commonly used to compensate and retain directors; they do not represent immediate ownership of shares until conversion and delivery. Because delivery is deferred and subject to vesting, this grant is primarily a compensation/retention event rather than a direct trading signal.